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SputumAims and objectives: Current methods for drug susceptibility testing (DST) of Mycobacterium
tuberculosis (MTB) are either costly or slow. As the prevalence of multidrug-resistant (MDR)
strains increases, the need for fast, reliable, and inexpensive methods is obvious. This
study evaluated a rapid colorimetric nitrate reductase assay (NRA) for direct DST of MTB
directly from clinical sputum samples.
Methods: A total of 111 sputa with positive microscopy results for acid-fast bacilli (AFB)
with more than 10 AFB per high-power field were used in the study. The samples were
decontaminated using the modified Petroff method. The NRA results were compared with
the reference indirect proportion method.
Results: The sensitivity and the specificity of the direct NRAwere 90% and 97.3%, 92.6% and
98.2%, 52.9% and 100%, and 28.6% and 100% for rifampin, isoniazid, streptomycin, and
ethambutol, respectively. The results were in most cases available in 28 days (84.3%).
Conclusions: The direct NRA could be used as a rapid, inexpensive, and accurate method to
determine rifampin and isoniazid susceptibility directly from sputum. The technique
might become a valid alternative to traditional methods, especially in low-income
countries.
 2015 Asian African Society for Mycobacteriology. Production and hosting by Elsevier Ltd.
All rights reserved.Introduction
Tuberculosis (TB) remains a major public health problem
worldwide worsened by the emergence of multidrug-
resistant tuberculosis (MDR-TB). In recent years, the inci-
dence of TB has been rising, and the World Health
Organization (WHO) has estimated the number of incident
new cases at 9 million and 1.5 million people have died fromthe disease in 2013. The proportion of new caseswith MDR-TB
was 3.5% [1].
In order to fight this situation, a rapid and inexpensive
drug susceptibility test (DST) is needed to allow a rapid
initiation of a correct antibiotic (ATB) therapy. Standard meth-
ods for DST, such as the proportion method, are used globally,
but depend on culture on solid media and are regrettably
time-consuming [2]. The time lag is a significant threat to
Fig. 1 – Sensitive strain to four antibiotics.
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rent techniques, genetic as well as phenotypic, have been
developed [3–6]. But those methods are globally either costly
or slow and are consequently not feasible in most low-
outcome countries. In view of these considerations, alterna-
tive rapid methods have been suggested, among them, the
nitrate reductase assay (NRA) on Loe¨wenstein–Jensen (LJ)
medium. It is simple to perform and has been successfully
implemented in low-resources countries [7,8]. This test is
based on the ability of Mycobacterium tuberculosis (MT) to
reduce nitrate to nitrite, which is revealed as a color change
in the culture medium, using the Griess method [9]. The indi-
rect (using isolates) NRA yields results in less than 14 days,
but requires an initial 3–4 weeks for the culture of the isolate.
So far, only a few studies have evaluated the NRA applied
directly on sputum samples.
The aim of the present study is to evaluate the perfor-
mance of the NRA applied directly on microscopy-positive
sputum samples from patients with pulmonary tuberculosis
(PTB) for the detection of resistance to the first-line anti-
tuberculosis drugs: rifampin (RIF), isoniazid (INH), strepto-
mycin (STR) and ethambutol (EMB).
Material and methods
Setting
Currently, the laboratory receives samples from patients liv-
ing in Sfax and suburbs and also from cities of the Tunisian
South and Center. All strains are cultured on standard LJ med-
ium, and the DST is performed with indirect proportion
method (IPM). After processing, specimens are stored at
20 C.
Specimen processing
From January 2009 to April 2014, a total of 111 sputa with pos-
itive microscopy results with AFB (acid-fast bacilli) having a
positivity score of 1+ or more were processed using the
Petroff decontamination method [10]. One milliliter of sterile
distilled water was added to the sediment.
IPM
An LJ tube was inoculated with 0.2 ml of undiluted decontam-
inated suspension and incubated for up to 60 days. Isolates
from this tube were used for IPM performed using LJ medium
according to standard protocol. The following critical concen-
trations were used: 0.2 lg/ml for INH, 40 lg/ml for RIF,
4.0 lg/ml for STR, and 2.0 lg/ml for EMB.
Direct NRA DST
The NRA was performed as described previously by A¨ngeby
et al. [11] on the difference in the use of sodium nitrate
(NaNO3) instead of potassium nitrate (KNO3). Standard LJ
medium was used with 1000 lg of NaNO3/ml and with or
without ATB. The same critical concentrations of ATB as
those used in the IPM were applied.Part of the decontaminated suspension was diluted 1:10 in
sterile distilled water. For each specimen, 0.2 ml of the diluted
preparation was inoculated into four drug-free LJ medium
tubes containing only NaNO3 (growth control tubes) and
0.2 ml of the undiluted suspension was inoculated into LJ
medium containing NaNO3 and each of the first-line ATB.
The tubes were incubated at 37 C.
After 7 days of incubation, 0.5 ml of freshly prepared
Griess reagent (1 part 50% concentrated hydrochloric acid,
2 parts 0.2% sulfanilamide, and 2 parts 0.1%
n-1-naphtylethylenediamine dihydrochloride) was added to
one drug-free tube. If any color appeared, the tube with ATB
was developed with the Griess reagent. If not, the other tubes
were re-incubated, and the procedure was repeated at day 10
(D10), day 14, and finally at day 28. Themedium color changes
to weak or strong pink. An isolate was considered to be resis-
tant if there was a color change in the ATB tube equal or
greater than that in the diluted growth control. An isolate
was considered to be susceptible if there was no color change
or a color change less than that in the diluted growth control
(Figs. 1–3). NRA was considered to be invalid if the nitrate
reaction was negative in the drug-free medium at day 28
despite the presence of colonies.
Quality control
For each batch of medium, internal quality control was done
using two known susceptibilities of MT strains: one fully sus-
ceptible and one MDR isolate.
Fig. 2 – Sensitive strain to EMB and STR resistant to RMP and
INH (MDR).
Fig. 3 – Resistant strain four ATB (MDR).
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The performance of the NRA was evaluated in comparison
with the IPM in terms of sensitivity, specificity, positivepredictive value (PPV), negative predictive value (NPV) and
agreement.Results
The NRA was completed on 83 of 111 sputa. Of the 28 speci-
mens for which testing was not completed, 25 were culture-
negative and three had invalid NRA results, with little or no
color in the growth control tubes. In total, 55 (66%) strains
were fully susceptible, 28 (34%) had different resistance pat-
terns and 9 (11%) were MDR.
The comparison of NRA and IPM (Table 1) showed a sensi-
tivity of 73.8%, a specificity of 98.9%, a PPV of 93.8%, an NPVof
94.4% and an agreement of 94.3%.
Good sensitivities and specificities were found for INH and
RIF, while some problems were encountered when tested for
sensitivities in detecting EMB and STR resistance (Table 1).
Specificities and agreement were excellent for the four ATB.
PPV and NPV gave satisfying results, except the PPV for RIF.
No positive results were obtained at D7 or D10. Time to
result (TTR) was 14 days in 13 (15%) sputa and 28 days in 70
(85%) sputa, which leads to a time saving of 56 days in com-
parison with the IPM. TTR depending on AFB score (Table 2)
shows that 95% (19/20) of 1+ specimens were positive at day
28 and 81% (51/63) of more than 1+ specimens were positive
at day 28. There was no statistical correlation between TTR
and AFB score (p = 0.24).Discussion
This study demonstrated high sensitivity and specificity of
the NRA, relative to IPM, in the identification of resistance
of MT to INH (sensitivity: 92.6%; specificity: 98.2%) and RIF
(sensitivity: 90%; specificity: 97.3%). Regarding the results,
this study demonstrates the potential usefulness of NRA as
a susceptible and specific screening tool, especially for the
detection of INH and RIF resistance. This is essential because
RIF and INH are the most valuable anti-TB agents. In
addition, RIF resistance is mostly combined with INH
resistance [12]. So, the NRA can be used as a marker of
multidrug resistance in low-outcome countries, and
clinicians can be highly confident of a diagnosis of INH or
RIF resistance by this technique.
However, the sensitivities in detecting resistance to STR
and EMB were far too low to be acceptable (52.9% and 28.6%,
respectively), whereas the specificities (abilities to find true
drug susceptibility) were excellent (100%) for both drugs.
This seemingly systematic discordance might be explained
by the difficulty of achieving the phenotypic tests for STR
and EMB admitted by several studies even by recommended
standard methods [13]. The poor sensitivity of EMB can also
be explained by the small number of resistant samples on
which the sensitivity was calculated.
Musa et al. [13] found sensitivities for INH, RIF, STR and
EMB, respectively, of 93%, 100%, 76% and 55%. Specificities
were about 100% for INH, RIF and STR and 99% for EMB,
whereas, Solis et al. [14], who worked only on RIF and INH,
showed 100% of specificity and, respectively, 93.5% and
99.1% of specificity. These results were consistent with the
Table 1 – Sensitivity, specificity, PPV, NPV and agreement of the NRA compared with those of the IPM for M. tuberculosis.
Nitrate Reductase Assay
S R Sensitivity Specificity PPV NPV Agreement
STR S 66 0 52.9% 100% 100% 89.2% 90.4%
R 8 9
INH S 55 1 92.6% 98.2% 96.2% 96.5% 96.4%
R 2 25
RIF S 71 2 90% 97.3% 81.8% 98.6% 96.4%
R 1 9
EMB S 76 0 28.6% 100% 100% 93.8% 94%
R 5 2
Total S 268 3 73.8% 98.9% 938% 94.4% 94.3%
R 16 45
R: Resistant; S: Susceptible; VPP: positive predictive value; NPV: negative predictive value; STR: streptomycin; INH: isoniazid; RIF: rifampicin;
EMB: ethambutol.
Table 2 – Time to result depending on AFB score.
AFB D14 D28 TOTAL
1+ 1 19 20
2+ 7 24 31
3+ 5 27 32
Total 13 70 83
D: Day.
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results of studies on this type of sampling are worse than
those made on MT strains because of the amount of bacilli
in the sputum, which is significantly lower than that obtained
after culture. Also, freezing sputum could induce an alter-
ation of the bacterial wall which precludes its growth [17].
Agreement for INH and RIF was about 96.4%, 94% for EMB
and 90.4% for STR. The recommendations of Laszlo et al. [18]
permit researchers to judge the quality of their work. This
study proposes as agreement rate targets of 99% RIF, 97% for
INH and 92% for STR and EMB. Only EMB satisfies this crite-
rion in the present work. Corrective measures should be con-
ducted to improve these results, such as increasing the
number of resistant samples and performing the IPM and
the NRA in the same conditions.
In this study, results were obtained, at the latest, in
28 days. This represents a great advantage, since indirect
methods require on average of 37 days (extremes: 27–51 days)
for primary isolation prior to performing the DST, which
needs 45 additional days for the final results. NRA leads to a
time savings of 56 days in comparison with the IPM.
Nevertheless, the majority (85%) of positive results were
obtained at D28 and only 15% at D14. Further reductions in
TTR are possible if another reading is taken at D21, as sug-
gested in the original protocol [19]. This parameter will be
considered in later studies.
As shown in Table 2, most sputa were positive at D28 inde-
pendently of their AFB score, which is not coherent with the
literature which found a proportional relationship between
TTR and AFB scores [13,20].Conclusion
In addition to its rapidity, the NRA has other obvious benefits
that would facilitate its institution in resource-poor countries.
Specifically, it requires very little training, because the
method differs only slightly from the conventional method
for DST on LJ medium. Furthermore, this method uses only
inexpensive and easily obtained reagents, does not require
maintenance of any specialized equipment, and requires
minimal laboratory space and staffing. In light of the results
of this study, it is believed that the NRA might then be used
either as a rapid screening tool alone or in combination with
other methods, especially in detecting INH and RIF resistance
and so in detecting MDR strains.
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